Cronos Group Inc

Cronos Group Inc(CRON)股票分析

$3.380

+0.010 (+0.30%)收盤時

Loading chart…
High
3.420
Open
3.340
VWAP
3.38
Vol
1.11M
Mkt Cap
893.91M
Low
3.330
Amount
3.75M
EV/EBITDA, TTM
15.62

Cronos Group Inc. is a global cannabinoid company engaged in building disruptive intellectual property by advancing cannabis research, technology and product development. The Company's diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, edibles and tinctures. Lord Jones is a premium adult-use cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer and edible categories. Lord Jones Ice Water Hash Fusions pre-rolls feature flower and terpene-rich ice water hash and are fitted with a branded ceramic tip. PEACE NATURALS is a global medical brand engaged in producing cannabis products. The Company distributes products under the PEACE NATURALS brand for the Canadian market and the Israeli, German, and United Kingdom medical markets.

AI analysis of Cronos Group Inc (CRON)

buy

Cronos Group Inc is a good buy right now due to its strong financial performance, including a record Q2 2026 net revenue of $53 million, which is a 58% year-over-year increase, and a gross margin of 53.69%. Additionally, the stock is currently priced at $3.38, which is significantly lower than the analyst price target of C$5.50, indicating substantial upside potential. The primary risk to consider is the forward P/E ratio of 20.45, which suggests that the stock may be overvalued if future earnings do not meet expectations.

Analyst Ratings (1)

-19.53% downside
Hold
0 Buy
1 Hold
0 Sell
Current: 3.38
最低
2.30
平均
2.72
最高
3.14

TD Securities

2026-05-12

目標價

Buy

TD Securities

2026-02-24

目標價

$4.50

Buy

Canaccord

2026-01-27

目標價

$4.25

Buy

CIBC

2024-05-15

目標價

$3.5

Buy

B of A Securities

2024-04-08

目標價

$2.5

Sell

估值指標

The current forward P/E ratio for Cronos Group Inc (CRON) is 20.45, compared to its 5-year average forward P/E of 382.04.

Forward P/E

Fair
5Y Average P/E
382.04
Current P/E
20.45
高估
1594.43
低估
-830.35

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-3.93
Current EV/EBITDA
15.62
高估
15.90
低估
-23.76

Forward P/S

Undervalued
5Y Average P/S
7.87
Current P/S
3.86
高估
11.77
低估
3.97

Alphio AI Price Scenarios for CRON

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%CRON

$3.12

情境價格

B

Base

Base · 50%CRON

$2.76

情境價格

B

Bear

Bear · 25%CRON

$2.38

情境價格

Whales holding CRON

A

Altria Group, Inc.

+ HoldingCRONBUD

+1.17%

3M Return

事件時間軸

2026-06-30 (ET)

17:30:00

Cronos Group Appoints ATB Capital Markets for Share Repurchases

2026-06-16 (ET)

16:30:00

Cronos Group Files Normal Course Issuer Bid

2026-05-11 (ET)

07:50:00

Cronos Reports Q1 Revenue of $45.21M

2026-04-23 (ET)

13:10:00

Roth Capital: Cannabis Products Rescheduled to Schedule 3

10:30:00

Trump Orders Medical Marijuana Products to Schedule III

資訊

CRON FAQ — answered by Alphio AI

Cronos Group Inc. is a global cannabinoid company engaged in building disruptive intellectual property by advancing cannabis research, technology and product development. The Company's diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, edibles and tinctures. Lord Jones is a premium adult-use cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer and edible categories. Lord Jones Ice Water Hash Fusions pre-rolls feature flower and terpene-rich ice water hash and are fitted with a branded ceramic tip. PEACE NATURALS is a global medical brand engaged in producing cannabis products. The Company distributes products under the PEACE NATURALS brand for the Canadian market and the Israeli, German, and United Kingdom medical markets. It operates in the Healthcare sector (MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry).

Cronos Group Inc is a good buy right now due to its strong financial performance, including a record Q2 2026 net revenue of $53 million, which is a 58% year-over-year increase, and a gross margin of 53.69%. Additionally, the stock is currently priced at $3.38, which is significantly lower than the analyst price target of C$5.50, indicating substantial upside potential. The primary risk to consider is the forward P/E ratio of 20.45, which suggests that the stock may be overvalued if future earnings do not meet expectations.

1 analysts cover CRON: 0 rate it Buy, 1 Hold and 0 Sell. The average price target is 2.72.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始